Integer Holdings Corporation

ITGR Healthcare Medical Devices

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024. In the quarter to June 2026, revenue fell 2.60%, EPS fell 34.9%, free cash flow grew 48.8% and total debt rose 4.96%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

126.70 0.02 −0.02%
Market cap
$4.3B
P/E
34.3×
Fwd P/E
27.6×
Dividend yield
—
F-score
6/9
Altman Z
2.34
Beneish M
−2.30
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
1,853.64 1,716.60 1,555.66 1,331.28 1,221.08 1,073.44 1,258.09 1,215.01 1,136.08 1,075.50
Revenue Growth
7.98% 10.35% 16.85% 9.02% 13.75% (14.68%) 3.55% 6.95% 5.63% 34.37%
Gross Profit
500.39 459.01 409.89 345.76 336.97 285.71 355.01 362.67 354.01 337.68
Operating Income
221.26 208.24 163.32 112.68 135.71 120.61 157.64 155.56 125.65 92.92
EBT
125.40 147.56 105.38 68.68 101.06 86.21 105.19 61.12 49.26 28.17
Income after Tax
102.83 121.05 89.14 59.75 93.02 77.26 91.22 47.03 87.09 24.88
Net Income Common
102.81 119.90 90.65 66.38 96.81 77.26 96.34 167.96 66.68 5.96
EPS (Diluted)
2.89 3.36 2.69 1.99 2.91 2.33 2.92 5.15 2.09 0.19
Shares (Diluted, Weighted)
35.59 35.65 33.76 33.36 33.26 33.11 33.04 32.60 32.06 30.97
Gross Margin
26.99% 26.74% 26.35% 25.97% 27.60% 26.62% 28.22% 29.85% 31.16% 31.40%
EBIT Margin
11.94% 12.13% 10.50% 8.46% 11.11% 11.24% 12.53% 12.80% 11.06% 8.64%
Net Profit Margin
5.55% 6.98% 5.83% 4.99% 7.93% 7.20% 7.66% 13.82% 5.87% 0.55%
Free Cash Flow Margin
5.67% 5.80% 3.87% 3.18% 8.49% 12.11% 9.31% 10.19% 9.02% 4.39%
EBITDA
358.81 323.33 270.22 206.71 224.03 204.71 243.30 293.65 239.36 190.72
EBIT
221.26 208.24 163.32 112.68 135.71 120.61 157.64 155.56 125.65 92.92

Show all line items

In millions of $ except per-share values · columns are period end dates